Edifoligide sodium

N/A

Report date: 2026/01/06 15:22:26
NME

Base Information

Drug NameEdifoligide sodium
Drug Alias NameEdifoligideE2F duplex decoyE2F decoy ODNE2F decoyCGT-021 +[7] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionE2F transcription factors modulators
TargetsE2F transcription factors
Therapy Area/IndicationsGraft Occlusion, VascularIschemiaHyperplasia +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAnesiva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnesiva Inc
Active IndicationsN/A
Inactive IndicationsGraft Occlusion, VascularIschemiaHyperplasia +[7] 

Other Information

ATC CodeN/A
Related LinksKEGG